Currently, AT-II-receptor antagonists are used either as monotherapy in patients who cannot tolerate ACE inhibitors or in combination with other antihypertensive agents. Angiotensin II-receptor ...

High blood pressure, or hypertension, affects more than 1 billion people globally. Many of them are prescribed angiotensin-converting enzyme inhibitors—better known as ACE-1 inhibitors (ACEIs)—and/or ...

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced systolic blood pressure in patients with ...

Use of this combination product should be reserved for patients who have not achieved the desired blood pressure-lowering effect with irbesartan monotherapy. It is recommended that this product be ...

Researchers in a new Chinese study discovered that “intensive blood pressure control" resulted in a 15% reduced dementia risk ...

Medical Care Technologies Inc. is proud to announce continued momentum in the rapidly growing memorabilia and collectibles ...

The primary medications used in the study to lower blood pressure were calcium channel blockers and angiotensin receptor blockers, Serwer noted. “These commonly prescribed medications have been ...

Participants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement ...

Nearly 1 in 5 adults with high blood pressure unknowingly take common meds that worsen it—like painkillers or decongestants.

TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health ...

Mineralys plans to provide additional data from the pivotal Phase 3 Launch-HTN at an upcoming medical conference and in a peer-reviewed publication. Additionally, the ongoing Transform-HTN open-label ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...